139 related articles for article (PubMed ID: 23137282)
1. Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells.
Alagaratnam S; Harrison N; Bakken AC; Hoff AM; Jones M; Sveen A; Moore HD; Andrews PW; Lothe RA; Skotheim RI
Stem Cells Dev; 2013 Apr; 22(7):1136-46. PubMed ID: 23137282
[TBL] [Abstract][Full Text] [Related]
2. A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells.
Gopalakrishna-Pillai S; Iverson LE
PLoS One; 2011; 6(6):e20663. PubMed ID: 21698279
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
4. The transcriptome profile of human embryonic stem cells as defined by SAGE.
Richards M; Tan SP; Tan JH; Chan WK; Bongso A
Stem Cells; 2004; 22(1):51-64. PubMed ID: 14688391
[TBL] [Abstract][Full Text] [Related]
5. Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Choi SC; Choi JH; Park CY; Ahn CM; Hong SJ; Lim DS
J Cell Physiol; 2012 Nov; 227(11):3678-92. PubMed ID: 22378194
[TBL] [Abstract][Full Text] [Related]
6. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell.
Walsh J; Andrews PW
APMIS; 2003 Jan; 111(1):197-210; discussion 210-1. PubMed ID: 12760378
[TBL] [Abstract][Full Text] [Related]
7. Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.
Snow GE; Kasper AC; Busch AM; Schwarz E; Ewings KE; Bee T; Spinella MJ; Dmitrovsky E; Freemantle SJ
BMC Cancer; 2009 Oct; 9():383. PubMed ID: 19874621
[TBL] [Abstract][Full Text] [Related]
8. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors.
Sperger JM; Chen X; Draper JS; Antosiewicz JE; Chon CH; Jones SB; Brooks JD; Andrews PW; Brown PO; Thomson JA
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13350-5. PubMed ID: 14595015
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming in inter-species embryonal carcinoma-somatic cell hybrids induces expression of pluripotency and differentiation markers.
Flasza M; Shering AF; Smith K; Andrews PW; Talley P; Johnson PA
Cloning Stem Cells; 2003; 5(4):339-54. PubMed ID: 14733752
[TBL] [Abstract][Full Text] [Related]
10. Extrinsic factors derived from mouse embryonal carcinoma cell lines maintain pluripotency of mouse embryonic stem cells through a novel signal pathway.
Kawazoe S; Ikeda N; Miki K; Shibuya M; Morikawa K; Nakano S; Oshimura M; Hisatome I; Shirayoshi Y
Dev Growth Differ; 2009 Feb; 51(2):81-93. PubMed ID: 19207180
[TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts.
Romanska HM; Tiziani S; Howe RC; Günther UL; Gulzar Z; Lalani el-N
Neoplasia; 2009 Dec; 11(12):1301-8. PubMed ID: 20019838
[TBL] [Abstract][Full Text] [Related]
12. hnRNPLL controls pluripotency exit of embryonic stem cells by modulating alternative splicing of Tbx3 and Bptf.
Wang X; Ping C; Tan P; Sun C; Liu G; Liu T; Yang S; Si Y; Zhao L; Hu Y; Jia Y; Wang X; Zhang M; Wang F; Wang D; Yu J; Ma Y; Huang Y
EMBO J; 2021 Feb; 40(4):e104729. PubMed ID: 33349972
[TBL] [Abstract][Full Text] [Related]
13. Detailed characterization of the mouse embryonic stem cell transcriptome reveals novel genes and intergenic splicing associated with pluripotency.
Kunarso G; Wong KY; Stanton LW; Lipovich L
BMC Genomics; 2008 Apr; 9():155. PubMed ID: 18400104
[TBL] [Abstract][Full Text] [Related]
14. Ectopic activation of WNT signaling in human embryonal carcinoma cells and its effects in short- and long-term in vitro culture.
Atlasi Y; van Dorsten RT; Sacchetti A; Joosten R; Oosterhuis JW; Looijenga LHJ; Fodde R
Sci Rep; 2019 Aug; 9(1):11928. PubMed ID: 31417131
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide gain-of-function screen identifies novel regulators of pluripotency.
Abujarour R; Efe J; Ding S
Stem Cells; 2010 Sep; 28(9):1487-97. PubMed ID: 20629179
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner.
Tonge PD; Andrews PW
Differentiation; 2010 Jul; 80(1):20-30. PubMed ID: 20427117
[TBL] [Abstract][Full Text] [Related]
17. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.
Heim KC; White KA; Deng D; Tomlinson CR; Moore JH; Freemantle SJ; Spinella MJ
Mol Cancer; 2007 Sep; 6():57. PubMed ID: 17880687
[TBL] [Abstract][Full Text] [Related]
18. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells.
Jung M; Peterson H; Chavez L; Kahlem P; Lehrach H; Vilo J; Adjaye J
PLoS One; 2010 May; 5(5):e10709. PubMed ID: 20505756
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.
Cinelli P; Casanova EA; Uhlig S; Lochmatter P; Matsuda T; Yokota T; Rülicke T; Ledermann B; Bürki K
BMC Dev Biol; 2008 May; 8():57. PubMed ID: 18500982
[TBL] [Abstract][Full Text] [Related]
20. Dual roles of Oct4 in the maintenance of mouse P19 embryonal carcinoma cells: as negative regulator of Wnt/β-catenin signaling and competence provider for Brachyury induction.
Marikawa Y; Tamashiro DA; Fujita TC; Alarcon VB
Stem Cells Dev; 2011 Apr; 20(4):621-33. PubMed ID: 21083502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
